Showing results (171-180 of 309) with videos related to
Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatinS Ruan, M F Okcu, R C Pong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaH M Kantarjian, R S Walters, M J Keating, et al.Leukemia|November 28, 2002
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patientsJ Q Guo, H Lin, H Kantarjian, et al.Blood|June 14, 2000
Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteinsM Konopleva, A M Tari, Z Estrov, et al.Cytokines and Molecular Therapy|March 1, 1995
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)E H Estey, H M Kantarjian, S O'Brien, et al.Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.Medical and Pediatric Oncology. Supplement|January 1, 1992
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell countsP Valent, C Sillaber, K Geissler, et al.Haematology and Blood Transfusion|January 1, 1990
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemiaB Clarkson, J Gaynor, C Little, et al.The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.Blood|September 15, 1996
A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemiaR Munker, T Kobayashi, E Elstner, et al.Pageof 31